tradingkey.logo

NeuroOne Medical Technologies Corp

NMTC
0.780USD
+0.045+6.16%
종가 02/06, 16:00ET시세는 15분 지연됩니다
39.02M시가총액
손실P/E TTM

NeuroOne Medical Technologies Corp

0.780
+0.045+6.16%

자세한 내용은 NeuroOne Medical Technologies Corp 회사

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

NeuroOne Medical Technologies Corp 정보

종목 코드 NMTC
회사 이름NeuroOne Medical Technologies Corp
상장일Nov 09, 2012
CEORosa (David A)
직원 수17
유형Ordinary Share
회계 연도 종료Nov 09
주소7599 Anagram Dr
도시EDEN PRAIRIE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호55344-7399
전화19524261383
웹사이트https://nmtc1.com/
종목 코드 NMTC
상장일Nov 09, 2012
CEORosa (David A)

NeuroOne Medical Technologies Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
816.44K
+200696.00%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
230.73K
-253.00%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
201.68K
+64877.00%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
103.08K
-11338.00%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
100.85K
-906.00%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+2.00%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
816.44K
+200696.00%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
230.73K
-253.00%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
201.68K
+64877.00%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
103.08K
-11338.00%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
100.85K
-906.00%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
92.00K
+2.00%

수익 분석

기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
Merchant Adventure Fund LP
8.33%
Bleichroeder LP
7.93%
Sio Capital Management, LLC
4.68%
Bard Associates Inc.
3.67%
The Vanguard Group, Inc.
3.13%
기타
72.26%
주주
주주
비율
Merchant Adventure Fund LP
8.33%
Bleichroeder LP
7.93%
Sio Capital Management, LLC
4.68%
Bard Associates Inc.
3.67%
The Vanguard Group, Inc.
3.13%
기타
72.26%
주주 유형
주주
비율
Investment Advisor
18.41%
Corporation
8.33%
Hedge Fund
6.50%
Individual Investor
4.57%
Investment Advisor/Hedge Fund
3.26%
Research Firm
0.55%
Venture Capital
0.04%
Bank and Trust
0.04%
기타
58.30%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
51
16.80M
33.31%
-652.40K
2025Q3
51
17.15M
34.30%
+9.56M
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
2023Q3
54
7.90M
33.50%
+2.01M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Merchant Adventure Fund LP
4.20M
8.33%
+2.95M
+236.00%
Dec 31, 2024
Bleichroeder LP
4.00M
7.93%
--
--
Sep 30, 2025
Sio Capital Management, LLC
2.36M
4.68%
-1.16M
-33.01%
Sep 30, 2025
Bard Associates Inc.
1.85M
3.67%
-3.60K
-0.19%
Sep 30, 2025
The Vanguard Group, Inc.
1.58M
3.13%
+375.64K
+31.24%
Sep 30, 2025
Perkins Capital Management, Inc.
1.47M
2.91%
-32.00K
-2.13%
Sep 30, 2025
AWM Investment Company, Inc.
916.67K
1.82%
--
--
Sep 30, 2025
Rosa (David A)
613.29K
1.22%
-2.46K
-0.40%
Dec 31, 2025
Renaissance Technologies LLC
692.60K
1.37%
+223.70K
+47.71%
Sep 30, 2025
Geode Capital Management, L.L.C.
496.83K
0.99%
+148.01K
+42.43%
Sep 30, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI